Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAP Block for PONV in Bariatric Surgery
NCT05016180Phase 2Unknown
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Sep 2020
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine in postoperative nausea and vomiting (PONV), sponsored by Tianjin Medical University General Hospital. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT05016180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05016180.